[FrontPageAfrica] Monrovia -- As thousands of Liberians and residents of Liberia get COVID-19 vaccination shots, the Liberia Medicines and Health Products Regulatory Authority (LMHRA), has disclosed that the Pharmacovigilance & Clinical Trials Department is monitoring the safety and adverse reactions of the AstraZeneca ChAdOx1 nCoV-19 (AZD1222) or COVID-19 vaccines, and is therefore urging the public to report all adverse reactions to the authority.
